Since breast cancer cells expressing CXCR4 tend to move toward regions of high CXCL12 expression16, 28, we asked whether ANGPTL2 knockdown and concomitant decreases in CXCR4 expression would alter the metastatic potential of MDA-MB231 cells. This evidence concerns the gene CXCL12 and breast cancer.